JPWO2021106857A1 - - Google Patents

Info

Publication number
JPWO2021106857A1
JPWO2021106857A1 JP2021561415A JP2021561415A JPWO2021106857A1 JP WO2021106857 A1 JPWO2021106857 A1 JP WO2021106857A1 JP 2021561415 A JP2021561415 A JP 2021561415A JP 2021561415 A JP2021561415 A JP 2021561415A JP WO2021106857 A1 JPWO2021106857 A1 JP WO2021106857A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021561415A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021106857A1 publication Critical patent/JPWO2021106857A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2021561415A 2019-11-29 2020-11-24 Pending JPWO2021106857A1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019217591 2019-11-29
PCT/JP2020/043624 WO2021106857A1 (ja) 2019-11-29 2020-11-24 尿意ストレス予防または緩和用組成物及び睡眠改善用組成物

Publications (1)

Publication Number Publication Date
JPWO2021106857A1 true JPWO2021106857A1 (ko) 2021-06-03

Family

ID=76130248

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021561415A Pending JPWO2021106857A1 (ko) 2019-11-29 2020-11-24

Country Status (2)

Country Link
JP (1) JPWO2021106857A1 (ko)
WO (1) WO2021106857A1 (ko)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7611738B2 (en) * 2005-05-24 2009-11-03 Pom Wonderful, Llc Processes for extracting phytochemicals from pomegranate solids and compositions and methods of use thereof
JP2005343809A (ja) * 2004-06-01 2005-12-15 K & G Nutrition:Kk 睡眠時における尿意の抑制剤
JP5690102B2 (ja) * 2010-08-28 2015-03-25 アサマ化成株式会社 泌尿器系疾患予防治療用組成物及びその製造方法
US9248154B2 (en) * 2012-07-06 2016-02-02 Pom Wonderful, Llc Methods and compositions for treatment of uriniary tract infections
TWI551293B (zh) * 2014-09-22 2016-10-01 大江生醫股份有限公司 香蕉花萃取物用於治療前列腺腫大及／或改善前列腺腫大引起排尿障礙的用途
EP3246040B1 (en) * 2015-01-14 2020-11-11 HLscience Co., Ltd Pomegranate extract for alleviating women's menopausal symptoms, containing high content of ellagic acid
GB201506526D0 (en) * 2015-04-17 2015-06-03 Uropharma Ltd And Synesis Llc Medicinal composition
JP7058939B2 (ja) * 2016-12-28 2022-04-25 小林製薬株式会社 ホスホジエステラーゼ５活性阻害用組成物
JP6412291B1 (ja) * 2017-01-20 2018-10-24 マルカイコーポレーション株式会社 頻尿の改善剤

Also Published As

Publication number Publication date
WO2021106857A1 (ja) 2021-06-03

Similar Documents

Publication Publication Date Title
BR112019017762A2 (ko)
BR112021017339A2 (ko)
BR112021013854A2 (ko)
BR112021018450A2 (ko)
BR112021017939A2 (ko)
BR112021017892A2 (ko)
BR112019016141A2 (ko)
AU2020104490A4 (ko)
BR112021017738A2 (ko)
BR112021017782A2 (ko)
BR112019016138A2 (ko)
BR112019016142A2 (ko)
BR112021018168A2 (ko)
BR112021017728A2 (ko)
BR112021008711A2 (ko)
BR112021018452A2 (ko)
BR112021017234A2 (ko)
BR112021017355A2 (ko)
BR112021017703A2 (ko)
BR112021017173A2 (ko)
BR112021018102A2 (ko)
BR112021017083A2 (ko)
BR112021017637A2 (ko)
BR112021012348A2 (ko)
BR112021018250A2 (ko)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20231010